Cargando…

SAA is Found on ApoB-Containing Lipoproteins in Obese Diabetic Humans

In murine models of obesity/diabetes there is an increase in plasma SAA levels along with redistribution of SAA from high density lipoprotein (HDL) to apo-B containing lipoprotein particles, namely low density lipoprotein (LDL) and very low density lipoprotein (VLDL). The goal of this study was to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahangiri, Anisa, Wilson, Patricia G, Hou, Tianfei, Brown, Aparna, King, Victoria L., Tannock, Lisa R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695410/ https://www.ncbi.nlm.nih.gov/pubmed/23784902 http://dx.doi.org/10.1002/oby.20126

Ejemplares similares

Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice
por: WU, JIANHUA, et al.
Publicado: (2014)

Proteoglycan binding as proatherogenic function metric of apoB-containing lipoproteins and chronic kidney graft failure
por: Steffen, Hannah L.M., et al.
Publicado: (2021)

MFGE8, ALB, APOB, APOE, SAA1, A2M, and C3 as Novel Biomarkers for Stress Cardiomyopathy
por: Pan, Xiao-Yu, et al.
Publicado: (2020)

The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017)

Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes
Publicado: (1992)

Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins
por: Wang, Liyun, et al.
Publicado: (2014)

Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake
por: Tognon, Gianluca, et al.
Publicado: (2012)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

Hepatic S1P deficiency lowers plasma cholesterol levels in apoB-containing lipoproteins when LDLR function is compromised
por: Basu, Debapriya, et al.
Publicado: (2015)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
por: Kido, Toshimi, et al.
Publicado: (2017)

ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
por: Vine, Donna F, et al.
Publicado: (2020)

ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity()
por: Lu, Min, et al.
Publicado: (2011)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice
por: Choe, Moon Kyung, et al.
Publicado: (2021)

Mouse, but Not Human, ApoB-100 Lipoprotein Cholesterol Is a Potent Innate Inhibitor of Streptococcus pneumoniae Pneumolysin
por: Wade, Kristin R., et al.
Publicado: (2014)

Evidence for Beneficial Associations between Isoenergetic Macronutrient Exchanges and Serum non-HDL Cholesterol, a Measure of All Circulating Atherogenic, apoB-Containing Lipoproteins
por: Griffin, Bruce A, et al.
Publicado: (2021)

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study
por: Walldius, Göran, et al.
Publicado: (2021)

Normal Weight Obesity: Role of apoB and Insulin Sensitivity in Predicting Future Cardiovascular Risk
por: Manapurath, Rukman M., et al.
Publicado: (2022)

Chylomicrons produced by Caco‐2 cells contained ApoB‐48 with diameter of 80–200 nm
por: Nauli, Andromeda M., et al.
Publicado: (2014)

ApoB48 as an Efficient Regulator of Intestinal Lipid Transport
por: Lo, Chunmin C., et al.
Publicado: (2020)

A Comparison of Lipids and apoB in Asian Indians and Americans
por: Singh, Kavita, et al.
Publicado: (2021)

High-Density Lipoproteins and Serum Amyloid A (SAA)
por: Webb, Nancy R.
Publicado: (2021)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE(-/-) mice
por: Dunér, Pontus, et al.
Publicado: (2021)

Serum SAA1 and APOE are novel indicators for human cytomegalovirus infection
por: Xie, Ni, et al.
Publicado: (2017)

HBV inhibits apoB production via the suppression of MTP expression
por: Wang, Fu-Bing, et al.
Publicado: (2011)

Serum ApoB levels in depressive patients: associated with cognitive deficits
por: Hui, Li, et al.
Publicado: (2017)

ApoB-Specific CD4(+) T Cells in Mouse and Human Atherosclerosis
por: Marchini, Timoteo, et al.
Publicado: (2021)

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
por: Quispe, Renato, et al.
Publicado: (2021)

Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice
por: Teivainen, Päivi A, et al.
Publicado: (2004)

Coalition of DNA polymorphisms of ApoB and ApoAI genes is related with coronary artery disease in Kazaks
por: Huang, Gang, et al.
Publicado: (2012)

The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients
por: Shidfar, Farzad, et al.
Publicado: (2012)

Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease
por: Sorokin, Alexander V., et al.
Publicado: (2023)

SUN-022 Metformin-Fish Oil Adjunct Therapy Improves apoB-Remnant Lipoprotein and Triglyceride Levels in Women with Polycystic Ovary Syndrome
por: Proctor, Ethan, et al.
Publicado: (2020)

Obesity contributes more to increasing ApoB/ApoA1 ratio than hyperandrogenism in PCOS women aged 20–38 years in China
por: Zheng, Jianhua, et al.
Publicado: (2017)

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013)

Relationship Between Adiponectin and apoB in Individuals With Diabetes in the Atlantic PATH Cohort
por: DeClercq, Vanessa, et al.
Publicado: (2017)

Identification of apoB‐100 Peptide‐Specific CD8+ T Cells in Atherosclerosis
por: Dimayuga, Paul C., et al.
Publicado: (2017)

Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

Elevated ApoB/apoA-1 is Associated with in-Hospital Mortality in Elderly Patients with Acute Myocardial Infarction
por: Chen, Yan, et al.
Publicado: (2023)

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents
por: Mason, R. Preston, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cs4kols88vvpabcl4airfq9sui